Name: Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice (Video) | JoVE Journal
Uploaded: 2022-06-29T15:00:00.000+00:00
Duration: 8 min 5 s
Description: Learn transesophageal atrial pacing to assess atrial fibrillation susceptibility in mice using optimized electrophysiological parameters. This method enables serial testing in the same animal for reproducible results.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

Figure 2 was created with BioRender.com. This work was supported by grants from the National Heart, Lung, and Blood Institute at the National Institutes of Health (HL096844 and HL133127); the American Heart Association (2160035, 18SFRN34230125 and 903918 [MBM]); and the National Center for Advancing Translational Sciences of the National Institute of Health (UL1 TR000445).

This procedure was approved by the Vanderbilt Institutional Animal Care and Use Committee and is consistent with the Guide for the Care and Use of Laboratory Animals. The protocol was developed using both genetic9 and acquired10 (e.g., hypertension) mouse models of AF susceptibility. The operator was blinded to the phenotype of the mouse under study.
1. Animal selection
<ol>
	<li>For genetic models, subject mice to biweekly (i.e., every other week) atrial pacing as described below (see step 6.) to determine the optimal period of AF susceptibility.
	<ol>
		<li>Begin biweekly pacing at 8 weeks of age. Use wild-type littermates as controls to reduce variability. Study both sexes, as one may not develop an AF phenotype9.</li>
	</ol>
	</li>
	<li>For acquired models, conduct pacing after mice achieve physical maturity (~12 weeks of age)10. As mentioned above, study both sexes.</li>
	<li>During these preliminary studies, perform both burst pacing8 (using a fixed pacing cycle length [CL]) and decremental pacing7 (with a progressively shorter pacing CL) to determine the optimal pacing mode. Separate each procedure by a minimum of 24 h. 
	NOTE: As an increasing number of mice are studied, review the accumulated data to determine the optimal age, sex, and pacing mode that promotes AF in AF susceptible mice but not controls.
	<ol>
		<li>Analyze the data using multiple definitions of AF susceptibility (e.g., number of AF episodes8, total AF duration9, AF incidence4, and sustained AF incidence, commonly defined as 10 s11 or 15 s12, and even up to 5 min13,14) as some models may display an AF phenotype for one but not all definitions9. 
		NOTE:The definition of an AF episode and AF susceptibility differ between published studies4,7. AF episodes8 are commonly defined as rapid atrial activity with an irregularly irregular&#160;ventricular response occurring for at least 1s (Figure 1). In addition to AF, atrial pacing may also induce atrial flutter with either a regular or irregular ventricular response.</li>
	</ol>
	</li>
	<li>Use the optimized model-specific parameters and definition of AF susceptibility for subsequent studies on additional mice.</li>
</ol>
2. Animal preparation
<ol>
	<li>Anesthetize the mouse in an induction chamber using 3% isoflurane (see Table of Materials) in 1 L/min of 100% oxygen. 
	NOTE: Isoflurane is harmful. It may irritate the skin or eye and can cause dizziness, fatigue, and headache, among other central nervous system toxicities. Use in a well-ventilated area with an appropriate scavenging method (e.g., activated carbon canister).</li>
	<li>After the loss of the pedal reflex, place the mouse in a supine position on a heating pad designed to maintain body temperature at approximately 37 &#176;C with the hindlimbs taped to the pad surface.</li>
	<li>Apply lubricating eye ointment to the eyes to prevent drying.</li>
	<li>Place an&#160;anesthetic mask securely over the mouse&#39;s nose. Begin maintenance of anesthesia using 1% isoflurane in 1 L/min of 100% oxygen. Ensure the nostrils are free from obstruction as mice are obligate nose breathers.</li>
	<li>Obtain a surface electrocardiogram (ECG, lead I) by the subcutaneous placement of 27 G ECG needle electrodes (see Table of Materials) connected to a biological amplifier and data acquisition hardware into the forelimbs. Ground the signal by placing a needle electrode into the left hind limb.</li>
</ol>
3. Catheter placement
<ol>
	<li>Briefly remove the isoflurane mask from the mouse.</li>
	<li>Insert a 2-F octapolar electrode catheter (electrode width and spacing = 0.5 mm) connected to a stimulator and stimulus isolator (see Table of Materials) into the esophagus (Figure 2).
	<ol>
		<li>Insert to a depth that approximates the distance from the mouth (with neck extended) to just above the xiphoid cartilage.</li>
	</ol>
	</li>
	<li>Reposition the isoflurane mask over the mouse&#39;s nostrils.</li>
	<li>Begin data acquisition with continuous recording of ECG lead I using analysis software (see Table of Materials).</li>
	<li>Adjust the stimulus isolator mode to bipolar. Use the distal-most pair of electrodes during stimulation.</li>
	<li>Properly position the catheter within the esophagus to enable capture. To do so, apply a 1.5 mA stimulus with a pulse width of 2 ms at a CL slightly shorter than the sinus CL (e.g., use a CL of 100 ms if the sinus CL is 120 ms). Carefully position the catheter until consistent atrial capture is obtained.</li>
</ol>
4. Threshold determination
<ol>
	<li>To determine the atrial diastolic capture threshold (TH), initiate pacing at 1.5 mA with a pulse width of 2 ms at the CL used for atrial capture. Decrease the stimulus amplitude by 0.05 mA increments until the loss of atrial capture, with subsequent increase until capture. 
	NOTE: The lowest amplitude at which consistent atrial capture is obtained is the atrial TH. Due to concern for parasympathetic stimulation at high stimulus amplitudes, which is reflected by excessive AV block during pacing with artifactual AF induction9, the maximum acceptable TH is 0.75 mA. If necessary, reposition the catheter to achieve a TH &#8804;0.75 mA.</li>
	<li>Adjust the stimulus amplitude to twice TH.</li>
</ol>
5. Determination of electrophysiologic properties
<ol>
	<li>Measure electrophysiologic parameters, including the sinus node recovery time (SNRT), Wenckebach cycle length (WCL), and atrioventricular effective refractory period (AVERP) prior to rapid atrial pacing for AF induction15.</li>
</ol>
6. Atrial arrhythmia susceptibility
<ol>
	<li>Perform pacing at twice TH with a pulse width of 2 ms using either burst pacing at different CLs or decremental pacing as determined from initial studies (steps 1.1.-1.4.).</li>
	<li>For burst pacing, pace at an initial CL of 50 ms for 15 s with subsequent trains occurring at CLs of 40 ms, 30 ms, 25 ms, 20 ms, and 15 ms8,10. Pause pacing for 30 s after each pacing train to allow for recovery before proceeding. If AF occurs after a pacing train, wait for 30 s after termination before proceeding with subsequent pacing.</li>
	<li>For decremental pacing, pace at a CL of 40 ms and decrease the CL by 2 ms every 2 s until termination at 20 ms7. Perform pacing trains in triplicate16 or quintuplicate17, with a 30 s pause for recovery following each train. As above, if AF develops, wait for 30 s after termination before proceeding. 
	NOTE: When optimizing protocol parameters during preliminary experiments (i.e., steps 1.1.-1.5.), perform decremental pacing with five trains. Conduct a post hoc analysis to determine if three or five trains provide the greatest sensitivity.</li>
	<li>Terminate the procedure upon 30 s of sinus rhythm following the last pacing train or after a 10 min episode of AF, whichever comes first.</li>
</ol>
7. Post-procedure
<ol>
	<li>Stop data acquisition.</li>
	<li>Gently remove catheter and ECG electrodes.</li>
	<li>Stop anesthesia.</li>
	<li>Place the anesthetized mouse into a cage and observe for 10 min to ensure recovery.</li>
	<li>Save the data file. In the case of serial testing, wait for a minimum of 24 h before repeating the pacing procedure.</li>
</ol>

<ol><li>Sumitomo, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Association+of+atrial+arrhythmia+and+sinus+node+dysfunction+in+patients+with+catecholaminergic+polymorphic+ventricular+tachycardia%5BTitle%5D)+AND+%22Circulation+Journal%22%5BJournal%5D)">Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia.</a> Circulation Journal. 71 (10), 1606-1609 (2007).</li>
<li>Fukui, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+of+leptin+signaling+in+the+pathogenesis+of+angiotensin+II-mediated+atrial+fibrosis+and+fibrillation%5BTitle%5D)+AND+%22Circulation%3A+Arrhythmia+and+Electrophysiology%22%5BJournal%5D)">Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation.</a> Circulation: Arrhythmia and Electrophysiology. 6 (2), 402-409 (2013).</li>
<li>Schutter, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Animal+models+of+atrial+fibrillation%5BTitle%5D)+AND+%22Circulation+Research%22%5BJournal%5D)">Animal models of atrial fibrillation.</a> Circulation Research. 127 (1), 91-110 (2020).</li>
<li>Li, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ryanodine+receptor-mediated+calcium+leak+drives+progressive+development+of+an+atrial+fibrillation+substrate+in+a+transgenic+mouse+model%5BTitle%5D)+AND+%22Circulation%22%5BJournal%5D)">Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model.</a> Circulation. 129 (12), 1276-1285 (2014).</li>
<li>Wakimoto, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Induction+of+atrial+tachycardia+and+fibrillation+in+the+mouse+heart%5BTitle%5D)+AND+%22Cardiovascular+Research%22%5BJournal%5D)">Induction of atrial tachycardia and fibrillation in the mouse heart.</a> Cardiovascular Research. 50 (3), 463-473 (2001).</li>
<li>Schrickel, J. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Induction+of+atrial+fibrillation+in+mice+by+rapid+transesophageal+atrial+pacing%5BTitle%5D)+AND+%22Basic+Research+in+Cardiology%22%5BJournal%5D)">Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing.</a> Basic Research in Cardiology. 97 (6), 452-460 (2002).</li>
<li>Verheule, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Increased+vulnerability+to+atrial+fibrillation+in+transgenic+mice+with+selective+atrial+fibrosis+caused+by+overexpression+of+TGF-beta1%5BTitle%5D)+AND+%22Circulation+Research%22%5BJournal%5D)">Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.</a> Circulation Research. 94 (11), 1458-1465 (2004).</li>
<li>Faggioni, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Suppression+of+spontaneous+ca+elevations+prevents+atrial+fibrillation+in+calsequestrin+2-null+hearts%5BTitle%5D)+AND+%22Circulation%3A+Arrhythmia+and+Electrophysiology%22%5BJournal%5D)">Suppression of spontaneous ca elevations prevents atrial fibrillation in calsequestrin 2-null hearts.</a> Circulation: Arrhythmia and Electrophysiology. 7 (2), 313-320 (2014).</li>
<li>Murphy, M. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Optimizing+transesophageal+atrial+pacing+in+mice+to+detect+atrial+fibrillation%5BTitle%5D)+AND+%22American+Journal+of+Physiology+-+Heart+and+Circulatory+Physiology%22%5BJournal%5D)">Optimizing transesophageal atrial pacing in mice to detect atrial fibrillation.</a> American Journal of Physiology - Heart and Circulatory Physiology. 332 (1), 36-43 (2022).</li>
<li>Prinsen, J. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Highly+reactive+isolevuglandins+promote+atrial+fibrillation+caused+by+hypertension%5BTitle%5D)+AND+%22JACC%3A+Basic+to+Translational+Science%22%5BJournal%5D)">Highly reactive isolevuglandins promote atrial fibrillation caused by hypertension.</a> JACC: Basic to Translational Science. 5 (6), 602-615 (2020).</li>
<li>Aschar-Sobbi, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Increased+atrial+arrhythmia+susceptibility+induced+by+intense+endurance+exercise+in+mice+requires+TNF%CE%B1%5BTitle%5D)+AND+%22Nature+Communications%22%5BJournal%5D)">Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα.</a> Nature Communications. 6, 6018(2015).</li>
<li>Bruegmann, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Optogenetic+termination+of+atrial+fibrillation+in+mice%5BTitle%5D)+AND+%22Cardiovascular+Research%22%5BJournal%5D)">Optogenetic termination of atrial fibrillation in mice.</a> Cardiovascular Research. 114 (5), 713-723 (2017).</li>
<li>Matsushita, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((IL-1%CE%B2+plays+an+important+role+in+pressure+overload-induced+atrial+fibrillation+in+mice%5BTitle%5D)+AND+%22Biological+and+Pharmaceutical+Bulletin%22%5BJournal%5D)">IL-1β plays an important role in pressure overload-induced atrial fibrillation in mice.</a> Biological and Pharmaceutical Bulletin. 42 (4), 543-546 (2019).</li>
<li>Sato, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cardiac+overexpression+of+perilipin+2+induces+atrial+steatosis%2C+connexin+43+remodeling%2C+and+atrial+fibrillation+in+aged+mice%5BTitle%5D)+AND+%22American+Journal+of+Physiology+-+Endocrinology+and+Metabolism%22%5BJournal%5D)">Cardiac overexpression of perilipin 2 induces atrial steatosis, connexin 43 remodeling, and atrial fibrillation in aged mice.</a> American Journal of Physiology - Endocrinology and Metabolism. 317 (6), 1193-1204 (2019).</li>
<li>Li, N., Wehrens, X. H. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Programmed+electrical+stimulation+in+mice%5BTitle%5D)+AND+%22Journal+of+Visualized+Experiments%22%5BJournal%5D)">Programmed electrical stimulation in mice.</a> Journal of Visualized Experiments. (39), e1730(2010).</li>
<li>Yao, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Enhanced+cardiomyocyte+NLRP3+inflammasome+signaling+promotes+atrial+fibrillation%5BTitle%5D)+AND+%22Circulation%22%5BJournal%5D)">Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation.</a> Circulation. 138 (20), 2227-2242 (2018).</li>
<li>Purohit, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Oxidized+Ca2%2B%2Fcalmodulin-dependent+protein+kinase+II+triggers+atrial+fibrillation%5BTitle%5D)+AND+%22Circulation%22%5BJournal%5D)">Oxidized Ca2+/calmodulin-dependent protein kinase II triggers atrial fibrillation.</a> Circulation. 128 (16), 1748-1757 (2013).</li>
<li>Jansen, H. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Atrial+fibrillation+in+aging+and+frail+mice%5BTitle%5D)+AND+%22Circulation%3A+Arrhythmia+and+Electrophysiology%22%5BJournal%5D)">Atrial fibrillation in aging and frail mice.</a> Circulation: Arrhythmia and Electrophysiology. 14 (9), 01077(2021).</li>
<li>Luo, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Characterization+of+atrial+histopathological+and+electrophysiological+changes+in+a+mouse+model+of+aging%5BTitle%5D)+AND+%22International+Journal+of+Molecular+Medicine%22%5BJournal%5D)">Characterization of atrial histopathological and electrophysiological changes in a mouse model of aging.</a> International Journal of Molecular Medicine. 31 (1), 138-146 (2013).</li>
<li>McCauley, M. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ion+channel+and+structural+remodeling+in+obesity-mediated+atrial+fibrillation%5BTitle%5D)+AND+%22Circulation%3A+Arrhythmia+and+Electrophysiology%22%5BJournal%5D)">Ion channel and structural remodeling in obesity-mediated atrial fibrillation.</a> Circulation: Arrhythmia and Electrophysiology. 13 (8), 00896(2020).</li>
<li>Kato, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Spectral+analysis+of+heart+rate+variability+during+isoflurane+anesthesia%5BTitle%5D)+AND+%22Anesthesiology%22%5BJournal%5D)">Spectral analysis of heart rate variability during isoflurane anesthesia.</a> Anesthesiology. 77 (4), 669-674 (1992).</li>
<li>Schmeckpeper, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Abstract+11402%3A+Targeting+RyR2+to+suppress+ventricular+arrhythmias+and+improve+left+ventricular+function+in+chronic+ischemic+heart+disease%5BTitle%5D)+AND+%22Circulation%22%5BJournal%5D)">Abstract 11402: Targeting RyR2 to suppress ventricular arrhythmias and improve left ventricular function in chronic ischemic heart disease.</a> Circulation. 144, Suppl_1 11402(2021).</li>
<li>Kim, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Abstract+B-PO01-017%3A+RyR2+hyperactivity+promotes+susceptibility+to+ventricular+tachycardia+in+structural+heart+disease%5BTitle%5D)+AND+%22Heart+Rhythm%22%5BJournal%5D)">Abstract B-PO01-017: RyR2 hyperactivity promotes susceptibility to ventricular tachycardia in structural heart disease.</a> Heart Rhythm. 18, Suppl_8 57(2021).</li>
</ol>

The authors have nothing to disclose.

Transesophageal atrial pacing not only allows serial studies in the same animal, but its duration is typically shorter than intracardiac studies (~20 min), thus minimizing anesthetic use and its effects on electrophysiologic parameters. 
It is critical to optimize the methods initially for each individual mouse model. Aging increases AF inducibility in normal mice18,19, and individual genetic models may demonstrate AF inducibility over...

Atrial fibrillation (AF) represents a final common pathway for multiple acquired and genetic risk factors. For studies investigating the pathophysiologic mechanisms of the AF substrate, mouse models are advantageous given the ease of genetic manipulation and the fact that, in general, they reproduce the AF susceptibility observed in humans for different clinical phenotypes1,2,3. However, mice rarely develop spontaneous AF4, necessitating the use of provocative atrial pacing studies.
Programmed electrical stimulation (PES) can be performed to assess murine atrial electrophysiology and AF susceptibility using either intracardiac5 or transesophageal6 pacing. While the transesophageal approach is particularly advantageous as a survival procedure, its use is complicated by the numerous published experimental protocols7,8 and sources of variability that can hinder reproducibility9. Moreover, limited reported protocol comparisons make selecting an appropriate pacing protocol challenging.
The current protocol aims to utilize a systematic strategy to develop model-specific transesophageal PES methods for assessing murine AF susceptibility in order to increase reproducibility. Importantly, initial pilot studies are performed to optimize the pacing protocol by accounting for age, sex, and pacing mode variability, with pacing designed to minimize inadvertent parasympathetic stimulation that can confound results9.

<table><tbody><tr><td>27 G ECG electrodes</td><td>ADInstruments</td><td>MLA1204</td><td></td></tr><tr><td>2-F octapolar electrode catheter</td><td>NuMED</td><td>CIBercath</td><td></td></tr><tr><td>Activated carbon canister</td><td>VetEquip</td><td>931401</td><td></td></tr><tr><td>Analysis software</td><td>ADInstruments</td><td>LabChart v8.1.13</td><td></td></tr><tr><td>Biological amplifier</td><td>ADInstruments</td><td>FE231</td><td></td></tr><tr><td>Data acquisition hardware</td><td>ADInstruments</td><td>PowerLab 26T</td><td></td></tr><tr><td>Eye ointment</td><td>MWI Veterinary</td><td>NC1886507</td><td></td></tr><tr><td>Heating pad</td><td>Braintree Scientific</td><td>DPIP</td><td></td></tr><tr><td>Isoflurane</td><td>Piramal</td><td>66794-017-25</td><td></td></tr><tr><td>Stimulator</td><td>Bloom Associates</td><td>DTU-210</td><td></td></tr><tr><td>Stimulus Isolator</td><td>World Precision Instruments</td><td>Model A365</td><td></td></tr></tbody></table>

optimization of transesophageal atrial pacing to assess atrial fibrillation susceptibility in mice

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Mouse models of genetic and acquired risk factors for atrial fibrillation (AF) have proven valuable in investigating the molecular determinants of AF. Programmed electrical stimulation can be performed using transesophageal atrial pacing as a survival procedure, thus enabling serial testing in the same animal. However, numerous pacing protocols exist, which complicates the reproducibility. The present protocol aims to provide a standardized strategy to develop model-specific experimental parameters to improve reproducibility between studies. Preliminary studies are performed to optimize the experimental methods for the specific model under investigation, including age at the time of the study, sex, and parameters of the pacing protocol (e.g., mode of pacing and definition of AF susceptibility). Importantly, care is taken to avoid high stimulus energies, as this can cause stimulation of the ganglionic plexi with inadvertent parasympathetic activation, manifested by exaggerated atrioventricular (AV) block during pacing and often associated with artifactual AF induction. Animals demonstrating this complication must be excluded from the analysis.

Transesophageal atrial pacing studies assess the electrophysiologic properties of the SA and AV nodes by determining the SNRT and AVERP, as well as AF susceptibility6 (Figure 1). ECG recording enables measurements of P wave duration, PR interval, QRS duration, and QT/QTc intervals. Continuous recording of the ECG during rapid atrial pacing can provide the following measurements of AF vulnerability: the number of episodes induced during the study, cumulative and averag...

The present protocol describes the optimization of experimental parameters when using transesophageal atrial pacing to assess atrial fibrillation susceptibility in mice.

Mouse models of genetic and acquired risk factors for atrial fibrillation (AF) have proven valuable in investigating the molecular determinants of AF. ...

optimization-transesophageal-atrial-pacing-to-assess-atrial

Research

JoVE Journal

Biology

Programmed electrical stimulation provides the ability to determine conduction properties of the heart, and the possibility to induce and terminate cardiac arrhythmias using various pacing protocols. Using a transvenous catheter, intracardiac electrogram recordings can be obtained in mice following programmed electrical stimulation protocols to identify arrhythmogenic substrates.

Programmed Electrical Stimulation in Mice

Here, we present a protocol for optical mapping of electrical activity from the mouse right atrium and especially the sino-atrial node, at a high spatial and temporal resolution.

High-resolution Optical Mapping of the Mouse Sino-atrial Node

This protocol describes the electrophysiological evaluation of murine atria utilizing an optical mapping system with a high temporal and spatial resolution, including dual recordings of the membrane voltage and Ca2+ transient under programmed stimulation through a specialized electrode catheter.

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping

Here we present a step-by-step protocol for a semiautomated approach to analyze murine long-term electrocardiography (ECG) data for basic ECG parameters and common arrhythmias. Data are obtained by implantable telemetry transmitters in living and awake mice and analyzed using Ponemah and its analysis modules.

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

This protocol aims to describe a new methodology to measure intrinsic cardiac firing rate using microelectrode array recording of the whole sinoatrial node tissue to identify pacemaking defects in mice. Pharmacological agents can also be introduced in this method to study their effects on intrinsic pacemaking.

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

We describe a sterile pericarditis model in minipigs to study atrial myopathy and atrial fibrillation (AF). We present surgical and anesthetic techniques, strategies for vascular access, and a protocol to study the inducibility of AF.

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

The present work describes an experimental protocol of transesophageal atrial burst pacing for efficient induction of atrial fibrillation (AF) in rats. The protocol can be used in rats with healthy or remodeled hearts, allowing the study of AF pathophysiology, identification of novel therapeutic targets, and evaluation of new therapeutic strategies.

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

We present a minimally invasive leporine model of long-term cardiac pacing that can be utilized for artificial pacing and heart failure development in preclinical studies.

Translational Rabbit Model of Chronic Cardiac Pacing

The present protocol describes obtaining the pressure-volume relationship through transesophageal pacing, which serves as a valuable tool in evaluating diastolic function in mouse models of heart failure.

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models

Right heart failure (RHF) is characterized by right-sided cardiac dilation and hypertrophy, leading to ventricular and atrial malfunction. Cardiopulmonary conditions associated with RHF are accompanied by an increased risk for cardiac arrhythmias. This article describes a standardized model of pulmonary artery banding-induced RHF associated with enhanced ventricular and atrial arrhythmogenesis.

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Learn transesophageal atrial pacing to assess atrial fibrillation susceptibility in mice using optimized electrophysiological parameters. This method enables serial testing in the same animal for reproducible results.

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Explore More Videos